v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
CURRENT ASSETS    
Cash and cash equivalents $ 18,411 $ 24,751
Research and development tax credit receivable 4,413 4,284
Other tax receivable 354 257
Prepaid expenses and other current assets 621 595
TOTAL CURRENT ASSETS 23,799 29,887
Equipment, net 1,262 955
Operating lease – right of use asset 1,247 914
Other assets 537 595
TOTAL ASSETS 26,845 32,351
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 5,053 7,768
Operating lease, current liabilities 812 623
TOTAL CURRENT LIABILITIES 5,890 8,416
Long-term operating lease liability 593 411
TOTAL LIABILITIES 6,483 8,827
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS’ EQUITY    
Preferred stock, $0.001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding
Common stock, $0.001 par value, 200,000,000 shares authorized, 27,653,789 and 26,585,258 shares issued and outstanding, respectively 28 27
Additional paid-in capital 237,688 233,271
Subscription receivable (814)
Accumulated other comprehensive loss (823) (737)
Accumulated deficit (215,717) (209,037)
TOTAL STOCKHOLDERS’ EQUITY 20,362 23,524
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 26,845 32,351
Related Party    
CURRENT LIABILITIES    
Accounts payable and accrued liabilities – related parties $ 25 $ 25